Dermatitis Herpetiformis Refractory to Gluten Free Diet
NCT ID: NCT05998291
Last Updated: 2023-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
23 participants
OBSERVATIONAL
2023-06-15
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. the natural course of refractory dermatitis herpetiformis and the development of possible complications
2. the strictness of gluten-free diet treatment in refractory dermatitis herpetiformis
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Mild Enteropathy Celiac Disease
NCT00628823
Celiac Disease and Infertility Among Men and Women in Denmark
NCT02451449
Serum Markers in Gluten Challenge
NCT00931892
Background of Different Phenotypes of Coeliac Disease
NCT05597904
Celiac Disease and Diabetes- Dietary Intervention and Evaluation Trial
NCT01566110
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study patients with refractory dermatitis herpetiformis will be recruited. As a control material dermatitis herpetiformis patients with good response to gluten-free dietary treatment will be recruited.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Refractory dermatitis herpetiformis patients
Dermatitis herpetiformis rash not controlled by strict glute-free diet
Assessment of prognosis of refractory dermatitis herpetiformis. No intervention
Assessment of prognosis of refractory dermatitis herpetiformis. No intervention
Dermatitis herpetiformis patients with good response to gluten-free diet
Dermatitis herpetiformis rash controlled by strict glute-free diet
Assessment of prognosis of refractory dermatitis herpetiformis. No intervention
Assessment of prognosis of refractory dermatitis herpetiformis. No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Assessment of prognosis of refractory dermatitis herpetiformis. No intervention
Assessment of prognosis of refractory dermatitis herpetiformis. No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Dermatitis herpetiformis diagnosis
* Dermatitis herpetiformis rash not responding to a strict gluten-free diet after at least 3 years
Control patients:
* Dermatitis herpetiformis diagnosis
* Dermatitis herpetiformis with good response to a gluten-free diet
Exclusion Criteria
-Not following strict gluten-free diet
Control patients:
-Not following a strict gluten-free diet
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tampere University
OTHER
University of Helsinki
OTHER
Tampere University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kaisa Hervonen, PhD
Role: PRINCIPAL_INVESTIGATOR
Tampere University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tampere University Hospital
Tampere, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R23003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.